From: Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019
Measure | Sex | Â | AAPC | Â | 95%CI | Â | t | Â | P | |
---|---|---|---|---|---|---|---|---|---|---|
Lower | Upper | Â | ||||||||
ASIR | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | Both |  | 5.8 |  | 5.4 | 6.1 |  | 32.3 |  | < 0.001 |
 | Male |  | 5.8 |  | 5.4 | 6.2 |  | 29.7 |  | < 0.001 |
 | Female |  | 5.6 |  | 5.3 | 6.0 |  | 35.6 |  | < 0.001 |
ASPR | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | Both |  | 5.9 |  | 5.4 | 6.4 |  | 24.2 |  | < 0.001 |
 | Male |  | 5.5 |  | 5.0 | 5.9 |  | 23.7 |  | < 0.001 |
 | Female |  | 6.5 |  | 6.0 | 6.9 |  | 27.6 |  | < 0.001 |
ASR of DALYs | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | Both |  | 4.6 |  | 4.2 | 5.0 |  | 22.2 |  | < 0.001 |
 | Male |  | 4.7 |  | 4.3 | 5.1 |  | 23.8 |  | < 0.001 |
 | Female |  | 4.5 |  | 4.1 | 4.8 |  | 23.6 |  | < 0.001 |
ASDR | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | Both |  | 4.4 |  | 4.0 | 4.8 |  | 21.6 |  | < 0.001 |
 | Male |  | 4.4 |  | 3.9 | 4.8 |  | 19.5 |  | < 0.001 |
 | Female |  | 4.3 |  | 3.8 | 4.8 |  | 17.5 |  | < 0.001 |